Keywords: Eli Lilly, Cialis, Prostatic hyperplasia, BPH, USA, FDA

FDA approves Lilly’s Cialis to treat benign prostatic hyperplasia

Article | 07 October 2011

Print This

The US Food and Drug Administration yesterday approved drug major Eli Lilly’s (NYSE: LLY) Cialis (tadalafil), currently marketed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in